What is Christopher Kling's NPI number?

Christopher Kling's National Provider Identifier (NPI) is 1467449934, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Christopher Kling's specialty?

Christopher Kling is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).

Where is Christopher Kling located?

Christopher Kling's practice location on file with NPPES is 16759 Main St, Wildwood, MO 63040-1232.

What is Christopher Kling's phone number?

The practice phone number listed in the NPPES registry for Christopher Kling is (636) 821-1661.

Does Christopher Kling accept Medicare?

Christopher Kling is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Christopher Kling's NPI active?

Yes — Christopher Kling's NPI (1467449934) is active in the NPPES registry as of the last update on 2009-08-13.

IndividualActiveAccepts Medicare

Christopher Kling, M.D.

NPI 1467449934 · Dermatology Physician · Wildwood, MO

Christopher Kling, M.D. is a Dermatology Physician provider in Wildwood, MO (NPI 1467449934).

Provider details

NPI number: 1467449934
Entity type: Individual
Primary specialty: Dermatology PhysicianAllopathic & Osteopathic Physicians
Credential: M.D.
Sex: Male
Sole proprietor: No
License: 2005001331 (MO)

Practice location

16759 Main St

Suite 201

Wildwood, MO 63040-1232

Phone: (636) 821-1661

Fax: (636) 821-1665

Street-level locationGet directions

More MO providers

Mailing address

16759 Main St

Wildwood, MO 63040-1232

Specialties & taxonomies

Dermatology PhysicianPrimary207N00000XLicense 2005001331 (MO)
Allopathic & Osteopathic Physicians

Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Detailed profile(87/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
21 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
5,344 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	2,186	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	1,068	$87
Destruction of Precancer Skin Growth, 1 Growth17000	710	$49
Destruction of Skin Growth, 1-14 Growths17110	561	$105
Biopsy of Related Skin Growth, First Growth11102	156	$82
New Patient Office Or Other Outpatient Visit With Low Level of Medical Decision Making, If Using Time, 30 Minutes Or More

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 27 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Ketoconazole	295	172
Hydrocortisone	241	173
Triamcinolone Acetonide	216	143
Doxycycline Hyclate	149	48
Cephalexin	146	85
Betamethasone Dipropionate	138	84
Clobetasol Propionate	111	70
Mupirocin	60	48

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$7,709 across 300 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2005-09-30
Last updated: 2009-08-13

Frequently asked questions

What is Christopher Kling's NPI number?: Christopher Kling's National Provider Identifier (NPI) is 1467449934, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Christopher Kling's specialty?: Christopher Kling is listed in the NPPES registry with a primary specialty of Dermatology Physician (Allopathic & Osteopathic Physicians).
Where is Christopher Kling located?: Christopher Kling's practice location on file with NPPES is 16759 Main St, Wildwood, MO 63040-1232.
What is Christopher Kling's phone number?: The practice phone number listed in the NPPES registry for Christopher Kling is (636) 821-1661.
Does Christopher Kling accept Medicare?: Christopher Kling is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Christopher Kling's NPI active?: Yes — Christopher Kling's NPI (1467449934) is active in the NPPES registry as of the last update on 2009-08-13.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Destruction of Precancer Skin Growth, 2-14 Growths17003	2,186	$6
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	1,068	$87
Destruction of Precancer Skin Growth, 1 Growth17000	710	$49
Destruction of Skin Growth, 1-14 Growths17110	561	$105
Biopsy of Related Skin Growth, First Growth11102	156	$82
New Patient Office Or Other Outpatient Visit With Low Level of Medical Decision Making, If Using Time, 30 Minutes Or More

Drug

Part D claims (2024)

Beneficiaries

Ketoconazole

295

172

Hydrocortisone

241

173

Triamcinolone Acetonide

216

143

Doxycycline Hyclate

149

Cephalexin

146

Betamethasone Dipropionate

138

Clobetasol Propionate

111

Mupirocin

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$7,709 across 300 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments